Dheyaa Kadhim Al-Waeli

Dheyaa Kadhim Al-Waeli

Auto-generated profile, based on publicly available information

Dheyaa Kadhim Al-Waeli

College of Medicine, University of Thi-Qar, Iraq

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2021 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
IHIbrahim Hani Hussein
Ibrahim Hani Hussein
AMAbbas Ali Mansour
Abbas Ali Mansour
HNHussein Ali Nwayyir
Hussein Ali Nwayyir
AAAmmar Mohammed Saeed Abdullah Almomin
Ammar Mohammed Saeed Abdullah Almomin
NANassar Taha Yaseen Alibrahim
Nassar Taha Yaseen Alibrahim
AAAli Hussain Ali Alhamza
Ali Hussain Ali Alhamza
Background: People from our region need a higher dose of vitamin D to maintain their serum 25(OH)D levels at concentrations greater than 20 ng/mL. This study aimed to obtain real data on vitamin D status in Basrah. Methods: Retrospective data analysis of patients seen over 2 years from May 2017 to the end of May 2019 at the Faiha Specialized Diabetes, Endocrine and Metabolism Centre (FDEMC) in Basrah, a tertiary referring center of southern Iraq. Results: The cohort included 3692 persons. Vitamin D deficiency was evident among 62.5% of the studied persons (66.5% of women and 48.7% of men). Univariate analysis for factors associated with vitamin D deficiency found it was significantly associated with female sex (OR, 2.095; 95% CI, 1.793 to 2.448; P<0.0001), age less than 44 years (OR, 2.6; 95% CI, 2.328 to 3.065; P<0.0001), nonmarried status (including single, widow and divorced) (OR, 0.768; 95% CI, 0.656 to 0.900; P<0.0001), nulliparous or unmarried status (OR, 0.684; 95% CI, 0.583 to 0.803; P<0.0001), housewife status (OR, 0.806; 95% CI, 0.673 to 0.967; P=0.020), and rural status (OR, 1.195; 95% CI, 1.034 to 1.382; P=0.016). No significant association was found between vitamin D deficiency and BMI. In multivariate logistic regression analyses, only female sex (OR, 0.513; 95% CI, 0.437 to 0.603; P<0.0001) and age less than 44 years (OR, 2.662; 95% CI, 2.252 to 3.147; P<0.0001), nulliparous or unmarried (OR, 0.814; 95% CI, 0.680 to 0.973; P=0.024) and rural residency (OR, 0.773; 95% CI, 0.647 to 0.924; P<0.0001) remained significantly associated. Conclusion: Women, a younger age, nulliparous, and a rural residency were associated with vitamin D deficiency.

1 April 2022 in Journal of Medicine and Life
Verified
Journal Article
Open access
DADheyaa Al-Waeli
Dheyaa Al-Waeli
AMAdel Mohammed
Adel Mohammed
ITImad Tahir
Imad Tahir
AAAli Al-Saeedi
Ali Al-Saeedi
KRKhdair Razzaq
Khdair Razzaq
AAAli Abodhurais
Ali Abodhurais
Diabetes mellitus is a disease with a high burden and prevalence and serious complications. Glycemic control is vital in delaying or preventing complications. Although many people do not take optimal doses, metformin is a cornerstone in managing type 2 diabetes mellitus (T2DM) in all guidelines. This study determined the barriers interfering with optimal metformin dosage. A cross-sectional study was conducted in Thi-Qar Specialized, Diabetes, Endocrine and Metabolism Center (TDEMC) at Thi-Qar, southern Iraq, from January 2019 to January 2020. 475 patients (274 females and 201 males) were included, and examination and lab investigations were performed. Only 22 (4.6%) patients took the optimal dose with no differences between gender. Of those who took metformin, 255 (74%) took it as a regular pill, 79 (23%) as a combined form with sulfonylureas (SUs), while only 10 (0.3%) took combined pills with Dipeptidyl Peptidase-4 inhibitors (DPP4i). 188 patients (65%) took metformin with meals, 84 (29%) before meals, and 19 (6%) after meals. Ignorance caused poor adherence to optimal dose in 165 patients (38.6%), neglect in 75 (17.6%), the cost in 5 (1.2%), 11 patients (2.6%) thought they did not need metformin, 37(8.7%) and 12 (2.8%) blame side effects and shortage of supply from public health care clinics (PHCC) as a cause, respectively. The rest of the patients had more than one cause. The most common side effects were abdominal pain and bloating, 5.9% and 3.8%, respectively. Other side effects were diarrhea in 0.2%, and 7.8% of patients developed more than one side effect. Ignorance and neglect were major obstacles, so educating doctors and patients and supplying the patient with optimal doses through PHCC may overcome the problem.

26 March 2026 in F1000Research
Verified
Journal Article
Open access
PDF file
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
DADheyaa Kadhim Al-Waeli
Dheyaa Kadhim Al-Waeli
SOSamih Abed Odhaib
Samih Abed Odhaib
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
Background This study aimed to evaluate the characteristics of diabetic foot ulcers in individuals with type 2 diabetes mellitus (T2DM) in Iraq. Methods The study included 881 participants with T2DM and different types of foot ulcers, who attended a specialized diabetes center. Data on demographics, clinical characteristics, biochemical investigations, comorbidities, and treatment regimens were collected and analyzed. Results The majority of the cases (96.8%) were due to T2DM, with an average age of 58 years and a mean BMI of 30 kg/m 2 . Participants had elevated serum creatinine, blood urea, and glucose levels, with uncontrolled HbA1c levels. Comorbidities included hypertension, ischemic heart disease, diabetic neuropathy, and retinopathy. Most participants were on insulin and statins. Diabetic foot ulcers were mainly on the right foot (48%) and classified as Grade 2 in Wagner’s system. Some participants had Charcot deformity or stages of amputation. Conclusions Random plasma glucose levels and diabetic retinopathy were significantly associated with the classification of foot ulcers. Further research is needed to explore additional variables related to T2DM and foot ulcers, emphasizing the importance of glucose control and retinopathy in ulcer classification.

1 January 2025 in Journal of Diabetes Research
Verified
Journal Article
Open access
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
NYNassar Taha Yaseen
Nassar Taha Yaseen
DADheyaa K AlWaeli
Dheyaa K AlWaeli
This research investigates the adherence levels to diabetes treatment among patients and explores the factors influencing adherence, glycemic control, and the occurrence of diabetes‐related complications. A cross‐sectional study involving 296 diabetes patients was conducted to evaluate their demographic and clinical profiles, treatment strategies, and adherence levels using the eight‐item Morisky Medication Adherence Scale (MMAS‐8). Statistical analyses identified variables affecting adherence and their relationships with glycemic control and complications. The study population comprised 56% men, with an average age of 49.4 years. Obesity was observed in 24.3% of participants, while the median disease duration was 5 years. The average HbA1c level was 8.4%. Microvascular complications were present in 48.6% of patients, and 18.2% experienced macrovascular complications. Most patients were prescribed oral antidiabetic medications (OAD), with 25% receiving insulin therapy. Adherence rates were suboptimal, with only 3.4% achieving good adherence, 30.4% moderate adherence, and 66.2% poor adherence. Men had higher rates of poor adherence compared to women (72.3% vs. 58.5%). Interestingly, adherence was better in patients with a longer disease duration and a higher body mass index (BMI). The study further examined adherence’s impact on glycemic outcomes, finding that poor adherence strongly correlated with elevated HbA1c levels. Among individuals with HbA1c ≥ 7 % , 70.5% exhibited poor adherence, whereas 40% of patients with good adherence still had suboptimal glycemic control. Conversely, among those with HbA1c < 7 % , 24.5% demonstrated poor adherence compared to 40% with good adherence. Random blood sugar (RBS) levels were significantly higher in poorly adherent patients (237 mg/dL) versus those with good adherence (141 mg/dL). Although adherence was not statistically linked to complication prevalence, patients with reported adherence challenges were more prone to both microvascular and macrovascular complications. Different treatment regimens were also analyzed, revealing that sulfonylureas (SUs) were associated with poor adherence (85%), while sodium–glucose cotransporter 2 inhibitors (SGLT2i) showed better adherence rates (16.7%). Missed doses were strongly linked to poor glycemic outcomes but had a lesser impact on complication development. These findings underscore the need for individualized strategies to enhance adherence and optimize glycemic control, ultimately reducing diabetes‐related complications.

19 March 2026 in Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
Verified
Journal Article
Open access
PDF file
DADheyaa Kadhim Al-Waeli
Dheyaa Kadhim Al-Waeli
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
SOSamih Abed Odhaib
Samih Abed Odhaib
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
SKShakir Aglah Khalifa
Shakir Aglah Khalifa
ITImad Hatim Tahir
Imad Hatim Tahir
The diagnostic performance of sonography to manage thyroid nodule (TN) may influence excess biopsy in different clinical settings. American College of Radiology (ACR) presented Thyroid Imaging Reporting and Data Systems (TIRADS) lator to American Thyroid Association (ATA) risk stratification guidelines, with variable diagnostic performance. The objective of this study is to evaluate the effectiveness of ACR-TIRADS versus ATA lexicons for thyroid cancer prediction among individuals with TN in Thi-Qar, Iraq. This cross-sectional observational study enrolled 1,007 individuals aged ≥ 14 years with 1,155 TNs attending a tertiary endocrine center. Malignancy risk was classified using both ACR-TIRADS and ATA lexicons with matched categories: TIRAD-1 (Benign<1%), TIRAD-2 (Very Low<3%), (TIRAD-3 (Low 5-10%), (TIRAD-4 (Intermediate 10-20%), and (TIRAD-5 (High 70-90%). Fine needle aspiration (FNAC) and histopathological diagnosis were made according to the Bethesda system and agreement between lexicons was assessed using sensitivity, specificity, Cohen’s Kappa Statistics, and McNemar test. Among participants, 85.2% were women, with mean age 46±14 years. Most individuals were euthyroid (71%), TNs were located in right lobe (51.3%), left lobe (42.5%), and isthmus (6.1%). FNAC was indicated for 54.6% of TNs by ATA and 44.6% by ACR-TIRADS criteria. High-risk cytology (Bethesda IV-V) was 7.1% and ATA system demonstrated higher sensitivity (74.3%) and accuracy (58.6%) than ACR-TIRADS (sensitivity 60%, accuracy 53%), though both gave modest diagnostic performance and low positive predictive values (<12%). Agreement between systems was weak (Cohen’s κ=0.265±0.032, p < 0.001), with concordance in 50.1% of cases. Both risk stratification systems had comparable but modest diagnostic performance. ATA identified more FNAC-eligible TNs with slightly higher sensitivity, specificity, prediction, and overall accuracy. However, the weak agreement between raters highlights variability in nodule categorization and management, supporting the need to integrate sonographic findings with clinical and biochemical factors to optimize TNs evaluation and minimize unnecessary biopsies.

17 July 2026 in Journal of Diabetes and Endocrine Practice
Verified
Journal Article
Open access
SOSamih Abed Odhaib
Samih Abed Odhaib
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
ITImad Hatim Tahir
Imad Hatim Tahir
AMAdel Gassab Mohammed
Adel Gassab Mohammed
DADheyaa Kadhim Al-Waeli
Dheyaa Kadhim Al-Waeli
MHMohammed Hassanein
Mohammed Hassanein
Primary objective: This article evaluates fasting behaviors, clinical outcomes, and adherence to medical guidance among individuals with diabetic foot ulcers (DFUs) during Ramadan. Secondary objective: This article explores the applicability and limitations of the Diabetes and Ramadan (DaR) risk score in individuals with DFUs, and identifies patient-level factors influencing the decision to fast. A real-world observational study (2021–2024) at a tertiary center in Thi-Qar, Iraq, involving 3,236 individuals with DFUs. Participants underwent pre-, intra-, and post-Ramadan evaluations, including DaR risk stratification, Wagner grading for DFU severity, metabolic profiling, and monitoring of fasting adherence, complications, and therapeutic changes. The data were processed and analyzed using IBM SPSS Statistics version 26. The descriptive analysis was done for all clinical parameters using mean, standard deviation, and frequency distributions. The comparative analysis employs chi-square tests to compare the fasting and nonfasting groups, and analysis of variance tests to compare the means of continuous parameters. All analyses were conducted at a 95% confidence interval, with p ≤ 0.05 considered statistically significant. Fasting individuals tend to be younger, had shorter diabetes duration, milder DFUs, and better metabolic profiles. However, some individuals who chose to fast demonstrate major high-risk features, including recurrent hypoglycemia and hypoglycemia unawareness, both of which are recognized by successive international Ramadan fasting guidelines as significant safety concerns warranting fasting interruption or avoidance. Self-monitoring of blood glucose adherence was suboptimal. Most fasters completed over half the month, but some discontinued due to dysglycemia, ulcer deterioration, or serious complications, including hospitalization, amputation, or cardiovascular events. The DaR score, while partially reflective outcome, did not account for DFU-related risks. This study highlights the need for DFU-specific considerations in risk assessments during the month of Ramadan. Despite the absence of formal guidance, many patients chose to fast based on perceived health status. The findings underscore the importance of individualized care, culturally informed counseling, and enhanced risk tools to support safe fasting decisions in this group.